(Q44868618)

English

Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome

scientific article published in May 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Acute renal failure after transarterial chemoembolization for hepatocellular carcinoma: a retrospective study of the incidence, risk factors, clinical course and long-term outcome (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

hepatocellular carcinoma

1 reference

based on heuristic

inferred from title

Yi-Hsiang Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

Huo TI

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Wu JC

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Chiang JH

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Lee PC

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Chang FY

6

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Lee SD

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

language of work or name

0 references

publication date

1 May 2004

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Alimentary Pharmacology & Therapeutics

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

19

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

9

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

999-1007

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Liver resection for hepatocellular carcinoma in cirrhotics and noncirrhotics. Evaluation of clinicopathologic features and comparison of risk factors for long-term survival and tumour recurrence in a single centre

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Systematic review of randomized trials for unresectable hepatocellular carcinoma: Chemoembolization improves survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Nephrotoxic effects in high-risk patients undergoing angiography

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Acute renal failure in patients with cirrhosis: perspectives in the age of MELD.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Risk of hepatic failure after transcatheter arterial chemoembolization for hepatocellular carcinoma: predictive value of the monoethylglycinexylidide test

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Renal failure in liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Risk factors for the development of renal dysfunction in hospitalized patients with cirrhosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

A model to predict survival in patients with end-stage liver disease

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Hepatorenal syndrome

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

The continuing increase in the incidence of hepatocellular carcinoma in the United States: an update

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Hepatocellular carcinoma in the elderly: results of surgical and nonsurgical management

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Lack of intratumoral heterogeneity in DNA ploidy pattern of hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Prognostic factors after hepatic resection for hepatocellular carcinoma with hepatitis C viral infection: univariate and multivariate analysis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Trans-catheter arterial chemoembolisation for hepatocellular carcinoma in patients with viral cirrhosis: role of combined staging systems, Cancer Liver Italian Program (CLIP) and Model for End-stage Liver Disease (MELD), in predicting outcome after

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Renal failure after upper gastrointestinal bleeding in cirrhosis: Incidence, clinical course, predictive factors, and short-term prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Prevention of nephrotoxicity induced by radiocontrast agents

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Ischemic hepatitis: clinical features, diagnosis and prognosis

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Acute renal failure after transarterial chemoembolization progressing to chronic renal failure in hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Acute renal failure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Comparison of MELD, Child-Pugh, and Emory model for the prediction of survival in patients undergoing transjugular intrahepatic portosystemic shunting

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2036.2004.01936.X

21 January 2018

Identifiers

10.1111/J.1365-2036.2004.01936.X

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44868618&oldid=2054743704"